AMBULANSAS, UAB - financials and debts

Company age: 27 y. 10 mo.

Update

AMBULANSAS - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 757,755 773,316 1,089,686 1,382,016 1,933,426 2,113,405 2,034,767 1,972,308
Profit before tax 25,347 28,262 68,530 19,198 74,908 93,936 7,905 -59,953
Net profit 25,347 28,262 68,530 19,198 74,908 93,936 7,905 -59,953
Equity 205,059 177,727 246,257 260,737 276,822 237,025 244,930 184,977
Liabilities 134,003 203,114 203,588 337,188 299,714 179,297 359,581 350,062
Non-current assets 240,853 260,891 255,981 324,179 274,769 93,461 420,205 363,655
Current assets 96,984 118,086 211,587 273,746 301,767 322,861 184,306 171,384
Total assets 337,837 378,977 467,568 597,925 576,536 416,322 604,511 535,039
Taxes paid
STI taxes - - - - - 261,435 225,423 297,003
Social insurance contributions - - - - - 304,642 334,800 348,263
Financial indicators
Revenue change y/y +8.4% +2.1% +40.9% +26.8% +39.9% +9.3% -3.7% -3.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 7.5% 7.5% 14.7% 3.2% 13.0% 22.6% 1.3% -11.2%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 12.4% 15.9% 27.8% 7.4% 27.1% 39.6% 3.2% -32.4%
Profit margin Net profit margin. Shows the overall profitability of the company. 3.3% 3.7% 6.3% 1.4% 3.9% 4.4% 0.4% -3.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 3.3% 3.7% 6.3% 1.4% 3.9% 4.4% 0.4% -3.0%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.7 1.1 0.8 1.3 1.1 0.8 1.5 1.9
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 17,157 17,509 21,903 26,792 38,863 41,439 37,856 35,644

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

AMBULANSAS - Social security debts

From To Debt, €
2026-05-12 2026-05-13 0.03
2025-10-23 2025-11-16 8.20
2025-07-24 2025-08-17 68.30
2025-06-17 2025-06-17 30405.05
2025-05-04 2025-05-15 82.30
2025-05-01 2025-05-01 82.30
2025-04-30 2025-04-30 26017.33
2025-04-24 2025-04-29 82.30
2025-04-16 2025-04-22 26017.33
2025-03-18 2025-03-20 26038.62
2025-02-18 2025-02-18 26034.81
2025-01-22 2025-02-17 32.81
2025-01-16 2025-01-21 27956.82
2024-12-17 2024-12-20 27020.66
2024-10-16 2024-10-20 26900.00
2023-10-25 2023-11-12 13.37
2023-05-02 2023-05-14 0.38
2023-04-26 2023-04-28 0.38
2023-03-16 2023-04-10 84.68
2021-11-16 2021-11-16 21368.64
2021-09-16 2021-09-19 16590.36

AMBULANSAS - VMI tax arrears

From To Overdue, €
2026-07-21 2026-08-09 887.52
2026-05-17 2026-05-17 10235.25
2025-09-25 2025-09-25 50.74
2025-09-17 2025-09-24 3222.96
2025-06-19 2025-07-20 40870.15
2025-07-08 2025-07-20 420.71
2025-06-18 2025-06-18 41851.34
2025-05-29 2025-06-17 42319.53
2025-05-28 2025-05-28 42330.57
2024-10-11 2024-10-16 139.68
2024-10-10 2024-10-10 23342.75
2024-10-09 2024-10-09 23336.02

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
AMBULANSAS, UAB (code 124633727) is a Private Limited Liability Company operating in patient transportation by ambulance. In 2025, the company generated revenue of €1.97M, down 3.1% year on year and 6.7% over two years. Profitability weakened materially: net profit moved from €93.9K in 2023 to €7.9K in 2024 and then to a €60.0K net loss in 2025, corresponding to a -3.0% profit margin. The balance sheet remained modest in size, with total assets of €535.0K, equity of €185.0K and liabilities of €350.1K at the end of 2025. Long-term assets accounted for €363.7K and short-term assets for €171.4K. Key ratios point to weaker returns and moderate leverage: ROE was -32.4%, ROA -11.2%, debt-to-equity 1.89 and asset turnover 3.69x. Productivity remained supported by the revenue base, with revenue per employee at €35.9K, while profit per employee was -€1.1K in 2025. Over 2023-2025, revenue declined gradually while earnings deteriorated sharply.